Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component

ClinicalTrials.gov ID

NCT07682597

Lead Sponsor

Timothy MullettOTHER

Overall Status

Recruiting

Study Type

Interventional

Phase

Not Applicable

Enrollment

200Estimated

Last Update Posted

Jul 6, 2026Actual

Start Date

Mar 1, 2026Actual

Primary Completion Date

Jul 1, 2028Estimated

Completion Date

Jul 1, 2029Estimated

Official Title

Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based

Brief Summary

This clinical trial studies whether a Quality Implementation of Lung Cancer Screening (QUILS™) System state-based initiative (SBI) intervention works to improve the statewide capacity for implementing and sustaining lung cancer screening in Mississippi (MS) and Nevada (NV). The QUILS™ Group is focused on fair and high-quality implementation of lung cancer screening among eligible individuals to reduce lung cancer-related death in underserved communities. Previous research had success with implementing interventions in Kentucky which has lead to significant increases in lung cancer screening rates and a rapid decline in late-stage lung cancer diagnoses within the state. The goal is to offer the opportunity to replicate this work in states which are eager to address suboptimal screening rates, high lung cancer-related death, and significant health equity concerns. The QUILS™ SBI intervention involves translating the success of the initial work in Kentucky to impact lung cancer screening implementation and lung cancer outcomes in MS and NV through close collaboration with state-based partners. The QUILS™ SBI intervention may be an effective way to improve the statewide capacity for implementing and sustaining lung cancer screening in MS and NV.

• Lung Cancer Screening

• QUILS SBI Intervention

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Member of a state-based lung cancer screening implementation team in Mississippi or Nevada.
• Leadership member of the Mississippi state team or Nevada state team
• Active member of the Mississippi Lung Cancer Roundtable (MSLCRT) or Nevada Lung Cancer Coalition (NLCC)
• Willing to participate in study-related assessments an implementation activities

Exclusion Criteria:

• None

Primary Purpose

Screening

Allocation

N/A

Interventional Model

Single Group Assignment

Masking

None (Open Label)

Lead Sponsor

Timothy MullettOTHER

joseph.alexander@uky.edu8593230892

joseph.alexander@uky.edu8593230892

joseph.alexander@uky.edu8593230892

• Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Health Services Research Intervention

  NCT07682610

  RecruitingInterventionalNot ApplicableUpdated Jul 6, 2026
• Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation

  NCT07639255

  RecruitingInterventionalNot ApplicableUpdated Jul 1, 2026
• Improving Implementation of Lung Cancer Screening in Diverse Populations II

  NCT05265897

  CompletedInterventionalNot ApplicableUpdated Mar 4, 2022
• Educating QUitline Callers About Lung Cancer Screening

  NCT05046951

  CompletedInterventionalPhase 3Updated Mar 29, 2023
• Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics

  NCT07716280

  RecruitingInterventionalNot ApplicableUpdated Jul 21, 2026
• Quality Improvement Pilot

  NCT05415800

  Enrolling by invitationInterventionalNot ApplicableUpdated Jan 20, 2025